---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-119013"
form_type: "8-K"
ticker: "HUMA"
cik: "0001818382"
company_name: "Humacyte, Inc."
filed_at: "2024-11-14T23:59:59+00:00"
generated_at: "2026-05-30T00:34:49.726111+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Humacyte prices $15M registered direct offering of common stock and warrants at $5.34/unit

## Summary
- Pricing of 2,808,988 shares and warrants to purchase up to 2,808,988 shares at $5.34 per unit on Nov 14, 2024.
- Gross proceeds of approximately $15M before expenses; closing expected on or about Nov 15, 2024.
- Warrants split: 1,404,494 expire in 180 days; 1,404,494 expire in four and one-half years, both at $5.34 exercise.
- Company agrees to no further equity issuance or variable rate transactions until FDA approval for extremity vascular trauma or 30 days.

## SEC filing metadata
- accession: 0001104659-24-119013
- form_type: 8-K
- ticker: HUMA
- cik: 0001818382
- company_name: Humacyte, Inc.
- filed_at: 2024-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818382/000110465924119013/0001104659-24-119013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818382/000110465924119013/tm2428460d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-119013
- JSON: https://secwatch.observer/filing/0001104659-24-119013.json
- Plain text: https://secwatch.observer/filing/0001104659-24-119013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.